Shares of Werewolf Therapeutics (NASDAQ:HOWL) added ~34% after announcing two partial remissions in an early-stage clinical program for WTX-124, one of its lead cancer candidates targeted at solid ...
Since early September, beachgoers have been reporting sightings of the unusual substance, leaving officials scrambling to determine its origin and composition.